Advisor Group Inc. Has $12.60 Million Stake in UnitedHealth Group Inc (UNH)

Advisor Group Inc. lessened its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 3.4% in the 3rd quarter, Holdings Channel reports. The firm owned 64,318 shares of the healthcare conglomerate’s stock after selling 2,238 shares during the quarter. Advisor Group Inc.’s holdings in UnitedHealth Group were worth $12,599,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of UNH. Blue Chip Partners Inc. purchased a new stake in shares of UnitedHealth Group during the 2nd quarter valued at $110,000. Bruderman Asset Management LLC purchased a new position in UnitedHealth Group in the 2nd quarter worth $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. raised its stake in UnitedHealth Group by 433.3% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after acquiring an additional 520 shares during the last quarter. BDO Wealth Advisors LLC purchased a new position in UnitedHealth Group in the 2nd quarter worth $121,000. Finally, Acrospire Investment Management LLC raised its stake in UnitedHealth Group by 130.7% in the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock worth $131,000 after acquiring an additional 400 shares during the last quarter. Hedge funds and other institutional investors own 86.01% of the company’s stock.

Shares of UnitedHealth Group Inc (UNH) opened at $228.64 on Friday. UnitedHealth Group Inc has a 12-month low of $156.09 and a 12-month high of $231.77. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70. The company has a market capitalization of $221,060.00, a PE ratio of 25.98, a PEG ratio of 1.57 and a beta of 0.66.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, beating the Zacks’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The firm had revenue of $50.32 billion for the quarter, compared to analysts’ expectations of $50.38 billion. During the same period last year, the firm earned $2.17 EPS. The company’s quarterly revenue was up 8.7% on a year-over-year basis. analysts predict that UnitedHealth Group Inc will post 9.99 earnings per share for the current fiscal year.

In related news, Director Michele J. Hooper sold 5,000 shares of UnitedHealth Group stock in a transaction dated Monday, December 4th. The stock was sold at an average price of $222.20, for a total value of $1,111,000.00. Following the sale, the director now directly owns 36,989 shares in the company, valued at approximately $8,218,955.80. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Larry C. Renfro sold 22,598 shares of UnitedHealth Group stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $221.75, for a total value of $5,011,106.50. Following the completion of the sale, the chief executive officer now owns 195,314 shares in the company, valued at $43,310,879.50. The disclosure for this sale can be found here. Insiders have sold a total of 34,630 shares of company stock worth $7,669,416 over the last 90 days. Insiders own 0.89% of the company’s stock.

A number of brokerages recently issued reports on UNH. Leerink Swann restated a “buy” rating and issued a $240.00 target price (up previously from $225.00) on shares of UnitedHealth Group in a research note on Wednesday, October 18th. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 target price for the company in a research note on Thursday, September 21st. Cantor Fitzgerald raised their target price on UnitedHealth Group to $225.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 18th. Oppenheimer raised their target price on UnitedHealth Group from $215.00 to $205.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 18th. Finally, Wells Fargo & Co restated an “outperform” rating and issued a $245.00 target price (up previously from $230.00) on shares of UnitedHealth Group in a research note on Wednesday, November 29th. Three investment analysts have rated the stock with a hold rating and twenty-five have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $229.54.

ILLEGAL ACTIVITY NOTICE: “Advisor Group Inc. Has $12.60 Million Stake in UnitedHealth Group Inc (UNH)” was first posted by Markets Daily and is the sole property of of Markets Daily. If you are accessing this report on another website, it was stolen and reposted in violation of US & international copyright laws. The legal version of this report can be viewed at https://www.themarketsdaily.com/2018/01/13/advisor-group-inc-has-12-60-million-stake-in-unitedhealth-group-inc-unh.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply